Table of Contents

• Reliability and Preliminary Validation of a Body Image Scale Survey for Use in Bladder Cancer Patients

  Ava Saidian, Hannah G Hingtgen ... Amirali Salmasi

  Extirpative bladder surgery for bladder cancer requires urinary diversion which causes cosmetic and functional changes that affect a patient’s body image and quality of life. Current health-related quality of life (HRQOL) surveys validated for use in bladder cancer patients have no dedicated domain evaluating body image. We sought to validate the ten-item Body Image Scale (BIS) for use in bladder ...

  RESEARCH | Published: 13 Oct 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 143-147   PDF(448KB)   Views：166Downloads：4

• Basic Study on Gene Biology of Bladder Cancer Metastasis

  Clara Joseph

  Bladder cancer is a complex disease with distinct treatment approaches based on its progression. For non-muscle invasive bladder cancer, the primary treatment method involves complete tumor resection, followed by immunotherapy, intravesical chemotherapy, and regular monitoring. In cases of muscle-invasive bladder cancer, a multimodal approach-including radical cystectomy and neoadjuvant chemother...

  REVIEW | Published: 13 Nov 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 148-157   PDF(1090KB)   Views：110Downloads：4

• The Role of Urinary Extracellular Vesicles in Kidney Cancer: Diagnostic and Therapeutic Potential

  Kirk Gallego

  Renal cancer ranks as the 14th most common cancer globally, with renal cell carcinoma (RCC) being the primary variant, arising from renal tubular epithelial cells; clear cell RCC constitutes about 80% of cases. Despite their limitations, surgery and targeted therapy remain the mainstays of RCC treatment. Regardless of advancements in RCC research, substantial obstacles continue to exist, such as d...

  REVIEW | Published: 17 Nov 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 158-167   PDF(2050KB)   Views：119Downloads：6

• Advances in Prostate Cancer Immunotherapy: Current Options and Emerging Novel Approaches

  Nasser S Alanazi, Mohammed H Alrafiah

  Prostate cancer (PCa) is a significant malignancy in men, contributing considerably to the rise in male mortality rates worldwide. Men diagnosed with PCa may have either localized or advanced stages of the disease. Globally, it ranks as the second most common and fifth most aggressive cancer type in males. The likelihood of developing prostate cancer in a man’s lifetime is approximately one in sev...

  REVIEW | Published: 26 Oct 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 168-176   PDF(1310KB)   Views：180Downloads：7

• Research Progress of AR Gene Family in Prostate Cancer Therapy

  Maham Khan

  Prostate cancer (PCa) is a malignancy originating from the epithelial cells of the prostate gland, strongly influenced by androgens, and is one of the most common cancers in men. Androgen deprivation therapy (ADT) is the primary treatment for prostate cancer. However, after prolonged ADT treatment, nearly all patients experience an increase in prostate-specific antigen (PSA) levels and tumor regro...

  REVIEW | Published: 18 Oct 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 177-184   PDF(1120KB)   Views：172Downloads：4

• Role of Hyperbaric Oxygen Therapy in Prostate Tumor Microenvironment and Cancer Stem Cell Niche

  Pranathi Konda, Merrel Holley, Vinoth Kumar Lakshmanan

  Hyperbaric oxygen therapy (HBOT), has gained attention in recent years as a potential adjunct to conventional cancer treatments, particularly in addressing tumor hypoxia which is extensively employed as a post-injury treatment, is the administration of >92% oxygen at 1.5- 3.0 ATA for 60-120 minutes. HBOT is attributed to at least five mechanisms including epigenetic regulation of gene expression, ...

  REVIEW | Published: 12 Dec 2024

  Annals of Urologic Oncology, Volume 7 (2024), Issue 4

  Pages: 185-194   PDF(1698KB)   Views：52Downloads：6